Amaro HM, Bautista-Samperio L, Arrieta PRT

Language: Spanish
References: 17
Page: 110-114
PDF size: 55.24 Kb.

ABSTRACT

Introduction: Breast cancer is the abnormal and disordered growth of cells of the epithelium in the mammary conducts, it has the capacity to scatter itself to any site of the organism. World-wide, its incidence has increased from 1940 being the first cause of death in women between 40 and 55 years of age. In Mexico 45.5% it is reported in minors of 50 years. Objective: To compare the correlation of risk factors for breast cancer with clinical findings between premenopause and postmenopause. Material and methods: A surway was made analytical, cross-sectional, prospective, comparative observational, in 168 women, divided in two groups of pre and postmenopause, age 30-80 years, not including those with menstrual, psychiatric or neoplasic upheaval. Risk factors and physical breast examination were done. Analysis with descriptive statistic coefficient of correlation of Spearman and Kruskal-Wallis with p=0.05. Results: Factor risk in both groups were found in the 46 and 50% respectively; it is to be remarked that nonevidence of mammary lesion was found in 56 and 66%. The correlation turned out to be weak in both groups. Conclusions: It predominates the moderate severity risk factors for breast cancer in premenopauses and postmenopauses, showing a weak correlation and without statistical significance between those and the clinical findings.

REFERENCES

1. Bereck SJ. Hillard P, Adashi E. Ginecología: Cáncer mamario 12va edición, México Mc Graw-Hill Interamericana 1997: 1283-91.

2. Abaunza H. Cáncer mamario: factores de riesgo. Rev Col Cirugía 1993; 8(1).

3. Galofre G, Pousiven L, Galofre M. Diagnóstico y tratamiento del cáncer de mama. Cirugía general y Ginecología. (Barc). Sept 2002.

4. Rodríguez-Cuevas S, Macías C, Labastida S. Cáncer de mama en México ¿Enfermedad de mujeres jóvenes? Ginec Obst Mex Vol. 68 Marzo 185-90.

5. Mun M, Gaxiola R. Perfil epidemiológico del cáncer en el Hospital de Ginecoobstetricia del Centro Médico de Occidente. Ginecología y Obstetricia de México. 2003; 71: 626-31.

6. Larios E, Trejo JA, Cortés M. Evaluación de la competencia clínica. Revista Médica del IMSS 1998; 36(1): 77-81.

7. Dexeus: Cáncer de mama. http// Zacatecas, gog.mx/SSZ/cáncer de Mama.htm

8. Vogel V. Cáncer de mama en mujeres más jóvenes. Http/latina.obgyn.net Nov 1999.

9. Wight R. Primary prevention of breast cancer: whither Tamoxifen? Ginecol Obstet Mex 2004; 104(3): 431-32.

10. Calderon-Garcidueñas A, Ruiz-Flores P, Cerda-Flores R, Barrera-Saldaña H. Clinical follow up of Mexican women with early onset of breast cancer and mutations of the BRCA1 and BRCA2 genes. Salud Pública de Mex 2005; 47(2): 110-15.

11. Torres MD. Tumores de mama diagnóstico y tratamiento; 2da. Edición Mc Graw-Hill Interamericana; 1998. 7-15.

12. Berry D, Tryback D, Cronin K. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005; 353(17): 1784-92.

13. Hill D. Self examination of the breast: is it beneficial? Meta-analysis of studies investigating breast self examination and extent of disease in patients with breast cancer; BMJ 1998; 297(6640): 271-5.

14. Poblano-Verastegui O, Figueroa Perea J, López Carrillo L. Condiciones institucionales que influyen en la utilización del examen clínico de mama. Salud Pública de Mex 2004; 46(4): 294-05.

15. Latorre L, Viana C. Guías clínicas en atención primaria cáncer de mama 2003 disponible en: Http://Fisterra.com

16. Ruisánchez PN, Alvarez BM, Menéndez AI, Ramírez BI. Alternativas preventivas en cáncer de mama. Rev Inst Nal Cancerol (Mex) 2000; 46(4): 232-236.

17. Diagnóstico de salud de la Unidad de Medicina Familiar No. 94 IMSS Aragón 2005.